181 related articles for article (PubMed ID: 11149899)
1. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
Shapiro L; Pott GB; Ralston AH
FASEB J; 2001 Jan; 15(1):115-122. PubMed ID: 11149899
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride.
Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889
[TBL] [Abstract][Full Text] [Related]
3. Dioxin activates human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells by enhancing NF-kappa B activity and production of tumor necrosis factor-alpha.
Gollapudi S; Kim CH; Patel A; Sindhu R; Gupta S
Biochem Biophys Res Commun; 1996 Sep; 226(3):889-94. PubMed ID: 8831706
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin.
Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T
J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798
[TBL] [Abstract][Full Text] [Related]
6. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
Zheng YT; Ben KL; Jin SW
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):239-43. PubMed ID: 10452099
[TBL] [Abstract][Full Text] [Related]
7. Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes.
Barcellini W; Colombo G; La Maestra L; Clerici G; Garofalo L; Brini AT; Lipton JM; Catania A
J Leukoc Biol; 2000 Nov; 68(5):693-9. PubMed ID: 11073109
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition of the human immunodeficiency virus type 1 by the oxygen radical generating agent bleomycin.
Georgiou NA; van der Bruggen T; Oudshoorn M; de Bie P; Jansen CA; Nottet HS; Marx JJ; van Asbeck BS
Antiviral Res; 2004 Aug; 63(2):97-106. PubMed ID: 15302138
[TBL] [Abstract][Full Text] [Related]
9. An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.
Shoji S; Furuishi K; Ogata A; Yamataka K; Tachibana K; Mukai R; Uda A; Harano K; Matsushita S; Misumi S
Biochem Biophys Res Commun; 1998 Aug; 249(3):745-53. PubMed ID: 9731208
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
Okamoto M; Ono M; Baba M
AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.
Baba M; Okamoto M; Kawamura M; Makino M; Higashida T; Takashi T; Kimura Y; Ikeuchi T; Tetsuka T; Okamoto T
Mol Pharmacol; 1998 Jun; 53(6):1097-103. PubMed ID: 9614214
[TBL] [Abstract][Full Text] [Related]
13. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.
Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1.
Congote LF
Biochem Biophys Res Commun; 2006 May; 343(2):617-22. PubMed ID: 16554023
[TBL] [Abstract][Full Text] [Related]
16. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.
Nakata H; Maeda K; Miyakawa T; Shibayama S; Matsuo M; Takaoka Y; Ito M; Koyanagi Y; Mitsuya H
J Virol; 2005 Feb; 79(4):2087-96. PubMed ID: 15681411
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages.
Chan ED; Kaminska AM; Gill W; Chmura K; Feldman NE; Bai X; Floyd CM; Fulton KE; Huitt GA; Strand MJ; Iseman MD; Shapiro L
Scand J Infect Dis; 2007; 39(8):690-6. PubMed ID: 17654345
[TBL] [Abstract][Full Text] [Related]
18. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro.
Witvrouw M; Schmit JC; Van Remoortel B; Daelemans D; Esté JA; Vandamme AM; Desmyter J; De Clercq E
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):187-92. PubMed ID: 9007204
[TBL] [Abstract][Full Text] [Related]
19. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
Angel JB; Saget BM; Walsh SP; Greten TF; Dinarello CA; Skolnik PR; Endres S
AIDS; 1995 Oct; 9(10):1137-44. PubMed ID: 8519449
[TBL] [Abstract][Full Text] [Related]
20. The effect of increasing alpha1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors.
Zhang XQ; Schooley RT; Gerber JG
J Infect Dis; 1999 Dec; 180(6):1833-7. PubMed ID: 10558938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
